Licensed in Human Biology (Pompeu Fabra University, 2023) and Master in Health and Science Management (Autonomous University of Barcelona, 2024), with a research stay in 2022 at the University of Heidelberg, at the National Center for Oncology Research (CNIO) in Madrid and at the Deutsch Krebs Forschung Zentrum (DKFZ), in the virology unit applied to tumors.
She joined Biocat in 2024 as coordinator of the d·HEALTH Barcelona Part-Time program, a training program in innovation and entrepreneurship inspired by the Biodesign methodology. This program allows identifying and solving real clinical needs that have an impact on patients' lives.